Surfing Follicular Waves in Ovarian Stimulation: is There a Role for LH in DuoStim Protocols? A Narrative Review and SWOT Analysis

Overview

Journal Reprod Biol Endocrinol

Publisher Biomed Central

Specialties Endocrinology
Reproductive Medicine

Date 2025 Feb 24

PMID 39994627

Authors

Alberto Vaiarelli

Danilo Cimadomo

Maria Cerrillo

Filippo Maria Ubaldi

Juan Antonio Garcia Velasco

Affiliations

Soon will be listed here.

Abstract

IVF treatments should be personalized to collect an appropriate number of oocytes, taking into account the woman's age and ovarian reserve, in order to maximize the efficacy and efficiency of the IVF process. From a scientific perspective, the 'continuous recruitment theory' suggests that several follicular waves are continuously recruited to grow and regress throughout one ovarian cycle. Clinically, this approach has paved the way for the theorization of a double stimulation protocol back-to-back in the same ovarian cycle (DuoStim) to rescue anovulatory waves. This protocol has been successfully adopted by several independent groups in the last decade to improve the number of oocytes in a short timeframe. Although the published data are promising for treating patients of advanced maternal age with reduced ovarian reserve and poor oocyte/embryo competence, the protocols adopted vary across studies. In this challenging population, choosing the appropriate protocol in the DuoStim context is critical to maximize the ovarian response and exploit the potential of individual follicular waves. In this regard, the administration of luteinizing hormone (LH) could be relevant to promote steroidogenesis and folliculogenesis, increase androgen production, improve pre-antral and antral follicle recruitment, and enhance the expression of follicle-stimulating hormone receptors in the granulosa cells. This review presents a step-by-step outline of all DuoStim protocols and proposes a SWOT (strengths, weaknesses, opportunities, threats) analysis of LH administration in the context of DuoStim.

References

Mihm M, Austin E, Good T, Ireland J, Knight P, Roche J . Identification of potential intrafollicular factors involved in selection of dominant follicles in heifers. Biol Reprod. 2000; 63(3):811-9. DOI: 10.1095/biolreprod63.3.811. View

Conforti A, Esteves S, Cimadomo D, Vaiarelli A, Di Rella F, Ubaldi F . Management of Women With an Unexpected Low Ovarian Response to Gonadotropin. Front Endocrinol (Lausanne). 2019; 10:387. PMC: 6610322. DOI: 10.3389/fendo.2019.00387. View

Marchiani S, Tamburrino L, Benini F, Pallecchi M, Bignozzi C, Conforti A . LH supplementation of ovarian stimulation protocols influences follicular fluid steroid composition contributing to the improvement of ovarian response in poor responder women. Sci Rep. 2020; 10(1):12907. PMC: 7395161. DOI: 10.1038/s41598-020-69325-z. View

Jin B, Niu Z, Xu B, Chen Q, Zhang A . Comparison of clinical outcomes among dual ovarian stimulation, mild stimulation and luteal phase stimulation protocols in women with poor ovarian response. Gynecol Endocrinol. 2018; 34(8):694-697. DOI: 10.1080/09513590.2018.1435636. View

Bourdon M, Santulli P, Maignien C, Pocate-Cheriet K, Marcellin L, Chen Y . The Ovarian Response After Follicular Versus Luteal Phase Stimulation with a Double Stimulation Strategy. Reprod Sci. 2020; 27(1):204-210. DOI: 10.1007/s43032-019-00012-9. View

Liu C, Jiang H, Zhang W, Yin H . Double ovarian stimulation during the follicular and luteal phase in women ≥38 years: a retrospective case-control study. Reprod Biomed Online. 2017; 35(6):678-684. DOI: 10.1016/j.rbmo.2017.08.019. View

Mennini F, Marcellusi A, Viti R, Bini C, Carosso A, Revelli A . Probabilistic cost-effectiveness analysis of controlled ovarian stimulation with recombinant FSH plus recombinant LH vs. human menopausal gonadotropin for women undergoing IVF. Reprod Biol Endocrinol. 2018; 16(1):68. PMC: 6052706. DOI: 10.1186/s12958-018-0386-2. View

Forman E, Li X, Ferry K, Scott K, Treff N, Scott Jr R . Oocyte vitrification does not increase the risk of embryonic aneuploidy or diminish the implantation potential of blastocysts created after intracytoplasmic sperm injection: a novel, paired randomized controlled trial using DNA fingerprinting. Fertil Steril. 2012; 98(3):644-9. DOI: 10.1016/j.fertnstert.2012.04.028. View

Sfakianoudis K, Pantos K, Grigoriadis S, Rapani A, Maziotis E, Tsioulou P . What is the true place of a double stimulation and double oocyte retrieval in the same cycle for patients diagnosed with poor ovarian reserve? A systematic review including a meta-analytical approach. J Assist Reprod Genet. 2019; 37(1):181-204. PMC: 7000611. DOI: 10.1007/s10815-019-01638-z. View

10.

Kuang Y, Chen Q, Hong Q, Lyu Q, Ai A, Fu Y . Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol). Reprod Biomed Online. 2014; 29(6):684-91. DOI: 10.1016/j.rbmo.2014.08.009. View

11.

Genro V, Grynberg M, Scheffer J, Roux I, Frydman R, Fanchin R . Serum anti-Müllerian hormone levels are negatively related to Follicular Output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation. Hum Reprod. 2010; 26(3):671-7. DOI: 10.1093/humrep/deq361. View

12.

Drakopoulos P, Blockeel C, Stoop D, Camus M, De Vos M, Tournaye H . Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?. Hum Reprod. 2016; 31(2):370-6. DOI: 10.1093/humrep/dev316. View

13.

Zegers-Hochschild F, Adamson G, Dyer S, Racowsky C, de Mouzon J, Sokol R . The International Glossary on Infertility and Fertility Care, 2017. Fertil Steril. 2017; 108(3):393-406. DOI: 10.1016/j.fertnstert.2017.06.005. View

14.

Wu Q, Li H, Zhu Y, Jiang W, Lu J, Wei D . Dosage of exogenous gonadotropins is not associated with blastocyst aneuploidy or live-birth rates in PGS cycles in Chinese women. Hum Reprod. 2018; 33(10):1875-1882. DOI: 10.1093/humrep/dey270. View

15.

Goldman K, Kramer Y, Hodes-Wertz B, Noyes N, McCaffrey C, Grifo J . Long-term cryopreservation of human oocytes does not increase embryonic aneuploidy. Fertil Steril. 2014; 103(3):662-8. DOI: 10.1016/j.fertnstert.2014.11.025. View

16.

Vaiarelli A, Cimadomo D, Conforti A, Schimberni M, Giuliani M, DAlessandro P . Luteal phase after conventional stimulation in the same ovarian cycle might improve the management of poor responder patients fulfilling the Bologna criteria: a case series. Fertil Steril. 2019; 113(1):121-130. DOI: 10.1016/j.fertnstert.2019.09.012. View

17.

Mochtar M, Danhof N, Ayeleke R, van der Veen F, van Wely M . Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles. Cochrane Database Syst Rev. 2017; 5:CD005070. PMC: 6481753. DOI: 10.1002/14651858.CD005070.pub3. View

18.

Barash O, Hinckley M, Rosenbluth E, Ivani K, Weckstein L . High gonadotropin dosage does not affect euploidy and pregnancy rates in IVF PGS cycles with single embryo transfer. Hum Reprod. 2017; 32(11):2209-2217. DOI: 10.1093/humrep/dex299. View

19.

Ngwenya O, Lensen S, Vail A, Mol B, Broekmans F, Wilkinson J . Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI). Cochrane Database Syst Rev. 2024; 1:CD012693. PMC: 10765476. DOI: 10.1002/14651858.CD012693.pub3. View

20.

Irani M, Canon C, Robles A, Maddy B, Gunnala V, Qin X . No effect of ovarian stimulation and oocyte yield on euploidy and live birth rates: an analysis of 12 298 trophectoderm biopsies. Hum Reprod. 2020; 35(5):1082-1089. DOI: 10.1093/humrep/deaa028. View